Ear nerve stimulation for early Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests whether a non-invasive nerve stimulation device (taVNS) worn on the ear can protect brain cells and slow Parkinson's disease progression in early-stage patients. It is for people who have been diagnosed within the last 3 years and are already on standard medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 75 years old.
- You have had Parkinson's disease for 3 years or less.
- You are currently taking standard Parkinson's medications.
- You have not had freezing episodes (sudden freezing while walking) or falls related to Parkinson's.
- You do not have a pacemaker, metal implants, or conditions that prevent MRI scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether gentle electrical stimulation of the ear (called TaVNS) can help relieve constipation in people with Parkinson's disease. If you have Parkinson's and struggle with constipation, this treatment aims to improve bowel function without medication.
This study tests whether a gentle nerve stimulation on the ear (taVNS) can improve movement symptoms in Parkinson's disease. It aims to understand how this stimulation affects the brain.
This trial tests whether a gentle electrical stimulation on your ear (taVNS) can help improve low motivation (apathy) in people with Parkinson's. It also uses MRI scans to see how the treatment affects the brain.
This study tests a type of nerve stimulation (vagus nerve) for Parkinson's disease. It compares a method that uses your breathing cycle to deliver stimulation versus standard stimulation. The goal is to see which works better for movement and non-movement symptoms.
This study tests whether a mild electrical stimulation on the ear (called taVNS) combined with treadmill walking can improve walking ability in people newly diagnosed with Parkinson's disease. The goal is to see if this combination helps you walk better and more safely.
This trial tests whether a gentle, non-invasive stimulation of the vagus nerve (a nerve that helps control heart rate and digestion) can improve walking and movement in people with Parkinson's disease. It may offer a new way to help with mobility problems.
Hear when a new Parkinson Disease, Idiopathic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.